Trade Greenwich LifeSciences, Inc. - GLSI CFD

Add to favourite

12.63

0.88%

View detailed chart

To be able to trade stocks like this, create an account and apply for a stock listing.

Create Account

Summary
Historical Data

Trading сonditions

Spread

0.30

Long position overnight fee

-0.023346%

Short position overnight fee

0.001124%

Overnight fee time

22:00 (UTC)

Min traded quantity

Currency

USD

Margin

5.00%

Stock exchange

United States of America

Commission on trade

Key Stats

Prev. Close	12.52
Open	12.63
1-Year Change	34.22%
Day's Range	12.46 - 12.95

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Jan 17, 2025	12.63	0.27	2.18%	12.36	13.01	12.36
Jan 16, 2025	12.52	0.30	2.45%	12.22	12.61	11.96
Jan 15, 2025	12.17	0.27	2.27%	11.90	12.47	11.90
Jan 14, 2025	11.93	-0.53	-4.25%	12.46	12.62	11.86
Jan 13, 2025	12.08	0.12	1.00%	11.96	12.56	11.81
Jan 10, 2025	12.34	-0.84	-6.37%	13.18	13.18	12.22
Jan 8, 2025	13.29	-0.42	-3.06%	13.71	13.73	12.89
Jan 7, 2025	13.51	0.43	3.29%	13.08	14.41	12.98
Jan 6, 2025	13.04	0.13	1.01%	12.91	13.34	12.71
Jan 3, 2025	12.75	1.03	8.79%	11.72	13.09	11.53
Jan 2, 2025	11.69	0.22	1.92%	11.47	12.19	11.46
Dec 31, 2024	11.19	0.58	5.47%	10.61	11.46	10.61
Dec 30, 2024	10.87	-0.24	-2.16%	11.11	11.17	10.47
Dec 27, 2024	11.37	-0.29	-2.49%	11.66	11.88	11.11
Dec 26, 2024	11.72	-0.22	-1.84%	11.94	12.33	11.56
Dec 24, 2024	11.96	-0.10	-0.83%	12.06	12.24	11.77
Dec 23, 2024	12.12	-0.24	-1.94%	12.36	12.38	11.77
Dec 20, 2024	12.17	-0.14	-1.14%	12.31	12.66	11.96
Dec 19, 2024	12.48	0.27	2.21%	12.21	12.73	12.07
Dec 18, 2024	12.24	-0.73	-5.63%	12.97	13.13	12.07

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

1:1
2:1
3:1
5:1
10:1
20:1

Leverage

20:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Greenwich LifeSciences, Inc. Company profile

Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent recurrence of breast cancer following surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.

Industry:

Biopharmaceuticals

3992 Bluebonnet Dr, Building 14
STAFFORD
TEXAS 77477
US

News

Ethereum price prediction: Third party data round up

What is the outlook for ETH as a long-term investment?

16:37, 7 January 2025

Euro forecast: third party data roundup

In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.

12:40, 31 December 2024

Pi Network coin price prediction: Third party price target

Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com

13:51, 13 December 2024

Projected US interest rates in 5 years: Third party round up

As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?

14:28, 12 December 2024

Street in City of London with Royal Exchange, Bank of England and new modern skyscrapers

Projected UK interest rates in 5 years

Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?

11:20, 12 December 2024